WANBURY : RECEIVES AUSTRALIAN TGA GMP CERTIFICATE FOR TANUKU PLANT

• Tanuku (Andhra Pradesh) API facility cleared by Australia's Therapeutic Goods Administration after inspection on 8-9 June 2026 • Certificate issued on 28 October 2026, valid until 9 December 2028, subject to TGA re-inspection requirements • Approval covers six APIs: Metformin HCl, Tramadol HCl, Sertraline HCl, Diphenhydramine HCl, Mefenamic Acid and Paroxetine HCl Hemihydrate • TGA will proceed with issuing GMP clearances to Australian sponsors, enabling supply of the approved APIs to the Australian market • Company's Tanuku and Patalganga facilities already hold USFDA and EUGMP approvals; APIs exported to over 50 countries

Wanbury Limited

Open attachment

← Back to feed